Zota Health Care Limited

ZOTA

INE358U01012

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:43:54 2024-05-28 EDT			5-day change	1st Jan Change
472.8 ^INR	+0.57%		-0.48%	+0.08%

03-08	Zota Health Care Limited Announces Resignation of Manukant Chandulal Zota as Whole-Time Director, Effective March 31, 2024	CI
02-08	Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Zota Health Care Limited Recommends Final Dividend for the Financial Year 2019-20

June 23, 2020 at 07:49 am

Zota Health Care Limited Recommended final dividend at the rate of 10% i,e. INR 1/- per equity share for the financial year 2019-20, subject to approval of shareholders at the upcoming Annual General meeting of the Company.

Latest news about Zota Health Care Limited

Zota Health Care Limited Announces Resignation of Manukant Chandulal Zota as Whole-Time Director, Effective March 31, 2024	03-08	CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-08	CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Zota Health Care Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-30	CI
Zota Health Care Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-30	CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Zota Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-13	CI
Zota Health Care Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-30	CI
Zota Health Care Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-30	CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-12	CI
Zota Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-01	CI
Zota Health Care Limited Recommends Final Dividend for the Financial Year 2020-21	21-09-14	CI
Zota Health Care Limited Receives Product Registration Licenses for Ten Products from Turkmenistan	21-09-14	CI
Zota Health Care Limited Proposes Declaration of Final Dividend for the Financial Year 2020-21	21-09-02	CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-07-30	CI
Zota Health Care Limited Receives Product Licenses from Ministry of Health, Cambodia	21-04-05	CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-02-10	CI
Zota Health Care Limited Receives Renewal of License to Work a Factory	20-11-12	CI
Zota Health Care Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	20-11-11	CI
Zota Health Care Limited Announces Launching of New Store Segment 'DAVAINDIA AYURVEDA & WELLNESS' Under Brand DAVAINDIA	20-09-04	CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	20-08-25	CI
Zota Health Care Limited Recommends Final Dividend for the Financial Year 2019-20	20-06-23	CI
3,545,712 Equity Shares of Zota Health Care Limited are subject to a Lock-Up Agreement Ending on 11-MAY-2020.	20-05-10	CI
Zota Health Care Limited Launches New Product with the Name "COROWL" for Viral Lnfection	20-04-28	CI

Chart Zota Health Care Limited

Duration

Period

More charts

Company Profile

Zota Health Care Limited is an India-based drug development, manufacturing and marketing company. The Company manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Companyâs business model comprises three verticals, namely Domestic, Exports and Retail Pharmacy Chain (Davaindia). Its Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Companyâs distribution network across India. It has a portfolio of more than 3,000 products in various categories, such as generics, OTC products, allopathic, ayurvedic and others. In the Retail Pharmacy Chain business vertical, it operates a chain of pharmacy stores under the brand Davaindia. Its domestic products include AMLOTOZ AT Tab, APIXACEED 2.5 Tab, APIXACEED 5 Tab, ATRONA 10 Tab, ATRONA 20 Tab, ATRONA 40 Tab, ATRONA ASP 75 Cap, ATRONA ASP 150 Cap, ATRONA ASP 20/75 Cap, ATRONA FB Tab and others.

Sector

Pharmaceuticals

Calendar

2024-06-28 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ZOTA HEALTH CARE LIMITED	+0.08%	142M
ELI LILLY AND COMPANY	+38.59%	727B
JOHNSON & JOHNSON	-7.89%	354B
MERCK & CO., INC.	+15.66%	328B
ABBVIE INC.	+0.24%	277B
ASTRAZENECA PLC	+13.47%	243B
NOVARTIS AG	+7.35%	205B
ROCHE HOLDING AG	-6.42%	203B
AMGEN INC.	+4.23%	164B
PFIZER, INC.	-1.70%	164B